NCT05265052 2026-03-113D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain3D MedicinesPhase 2 Not yet recruiting177 enrolled
NCT06897917 2025-03-27Real World Study of Oxycodone/Naloxone Sustained-Release Tablets (Mimeixin) for Patients With Severe Cancer PainHenan Cancer HospitalPhase 4 Not yet recruiting203 enrolled